Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pap-smear test today]

R Giannone1, C Piacezzi, G Panizzardi

  • 1Divisione Ostetrico-Ginecologica, Presidio Ospedaliero di Casorate Primo, USSL 77 Regione Lombardia.

Minerva Ginecologica
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The addition of respiratory muscle strength training to facilitate swallow and pulmonary rehabilitation following massive tissue loss and severe deconditioning: A case series.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2021
Same author

Efficacy and tolerability of a spray formulation containing Visnadine in women self-reporting sexual symptoms: a randomized double-blind placebo-controlled pilot study.

Journal of endocrinological investigation·2017
Same author

[A rare cause of uterine rupture during pregnancy].

Minerva ginecologica·1995
Same author

[Piperacillin in prevention and therapy in gynecological surgery].

Minerva ginecologica·1995
Same author

[The Pap-test in the study of viral infections of the female genital tract].

Minerva ginecologica·1995
Same author

[Risk factors of endometrial carcinoma].

Minerva ginecologica·1993
Same journal

High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup.

Minerva ginecologica·2021
Same journal

Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial.

Minerva ginecologica·2020
Same journal

[Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].

Minerva ginecologica·2020
Same journal

Update on new imaging technologies in sentinel node detection.

Minerva ginecologica·2020
Same journal

Postoperative pelvic dysfunctions associated with the reconstruction of the pelvic floor.

Minerva ginecologica·2020
Same journal

The role of sentinel-node biopsy in ovarian cancer.

Minerva ginecologica·2020
See all related articles

Regular Pap-Smear tests are crucial for early cervical cancer detection. Annual screening for women with HPV infection or risk factors can significantly reduce mortality rates.

Area of Science:

  • Gynecology
  • Oncology
  • Public Health

Context:

  • The Papanicolau and Traut monograph in 1943 marked a significant advancement in cervical cancer screening.
  • Cervical cancer remains a significant public health concern globally.
  • The Pap-Smear (Papanicolaou smear) has been a cornerstone of cervical cancer detection for decades.

Purpose:

  • To review the historical use and current impact of the Pap-Smear.
  • To analyze the various risk factors associated with cervical carcinoma.
  • To propose enhanced screening strategies for improved cervical cancer prevention.

Summary:

  • The Pap-Smear test has demonstrated widespread utility since its inception.
  • Cervical cancer risk is influenced by factors including HPV infection.

Related Experiment Videos

  • Annual Pap-Smear screening is recommended for high-risk women to reduce morbidity and mortality.

    • Impact:

    • Implementing annual Pap-Smear screening for at-risk populations can potentially improve outcomes by up to 90%.
    • Early detection through regular screening is key to reducing cervical cancer death rates.
    • This strategy aims to further decrease the incidence and mortality of cervical neoplasia.